
Guideline Toplines: 2021 Clinical Focus Collection
The Guideline Toplines slide-show feature offers busy primary care physicians at-a-glance summaries of new and updated clinical guidelines across therapeutic areas.
Clinical practice guidelines and treatment decision pathways for multiple therapeutic areas were updated this year.
To help health care professionals stay on top of key additions and other changes to these evidence-based, "living" documents, Patient Care summarizes newly published updates in its Guideline Topline slide show feature.
Following is the 2021 Patient Care Clinical Focus Collection of Guideline Topline slide shows, offering at-a-glance reviews of updated guidance for cardiovascular disease, sexually transmitted infections, C. diff infection, NAFLD/ and NASH, plus others.
The influenza and SARS-CoV-2 viruses once again are in cocirculation. Get a topline look at the NIH guideline on their simultaneous management.
Chest pain evaluation requires timely and accurate distinction between serious and benign causes. The 2021 ACC/AHA guideline authors provide 10 important reminders.
The 2021 American College of Gastroenterology guidelines on management of C. difficile reflect an expanding body of evidence for preventing, diagnosing, and treating the dangerous infection.
The CDC released the first set of new STI guidelines since 2015.
Assessment of CVD risk is the foundation of primary prevention and integral to primary care. Brush up on the fundamental tools of risk estimation from the ACC/AHA guidelines.
The most recent update to NIH COVID-19 Treatment Guidelines incorporates RCT data on use of antivirals, immunomodulators, and colchicine as treatment for SARS-CoV-2 infection.
The 2020 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline integrates new treatments and practices with existing management strategies for CKD patients with diabetes.
These updates include guidance on use of colchicine, when to use combination anti-SARS-CoV-2 monoclonal antibodies, COVID-19 reinfection, and "long COVID."
For patients with moderate-to-severe persistent asthma, new guidelines from the NAEPP recommend SMART, particularly for patients with a recent disease exacerbation.
Get a topline review of OA pain management recommendations from the Osteoarthritis Research Society International and the American College of Rheumatology/Arthritis Foundation.
Is pharmacotherapy always the most effective treatment for major depressive disorder? ACP guideline writers weigh in on this topic and others that may influence your clinical practice.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

































































































































































































































































































